-
Je něco špatně v tomto záznamu ?
Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients
HM. Eid, ML. Wright, NV. Anil Kumar, A. Qawasmeh, STS. Hassan, A. Mocan, SM. Nabavi, L. Rastrelli, AG. Atanasov, PS. Haddad,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
28713266
DOI
10.3389/fphar.2017.00387
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Metabolic syndrome is a cluster of three or more metabolic disorders including insulin resistance, obesity, and hyperlipidemia. Obesity has become the epidemic of the twenty-first century with more than 1.6 billion overweight adults. Due to the strong connection between obesity and type 2 diabetes, obesity has received wide attention with subsequent coining of the term "diabesity." Recent studies have identified unique contributions of the immensely diverse gut microbiota in the pathogenesis of obesity and diabetes. Several mechanisms have been proposed including altered glucose and fatty acid metabolism, hepatic fatty acid storage, and modulation of glucagon-like peptide (GLP)-1. Importantly, the relationship between unhealthy diet and a modified gut microbiota composition observed in diabetic or obese subjects has been recognized. Similarly, the role of diet rich in polyphenols and plant polysaccharides in modulating gut bacteria and its impact on diabetes and obesity have been the subject of investigation by several research groups. Gut microbiota are also responsible for the extensive metabolism of polyphenols thus modulating their biological activities. The aim of this review is to shed light on the composition of gut microbes, their health importance and how they can contribute to diseases as well as their modulation by polyphenols and polysaccharides to control obesity and diabetes. In addition, the role of microbiota in improving the oral bioavailability of polyphenols and hence in shaping their antidiabetic and antiobesity activities will be discussed.
Applied Biotechnology Research Center Baqiyatallah University of Medical SciencesTehran Iran
Department of Chemistry Manipal Institute of Technology Manipal UniversityManipal India
Dipartimento di Farmacia University of SalernoFisciano Italy
Faculty of Pharmacy Hebron UniversityHebron Palestine
Nell Hodgson Woodruff School of Nursing Emory UniversityAtlanta GA United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17032054
- 003
- CZ-PrNML
- 005
- 20171030122845.0
- 007
- ta
- 008
- 171025s2017 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fphar.2017.00387 $2 doi
- 035 __
- $a (PubMed)28713266
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Eid, Hoda M $u Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology and Physiology, Université de MontréalMontréal, QC, Canada. Canadian Institutes of Health Research Team in Aboriginal Antidiabetic MedicinesMontréal, QC, Canada. Department of Pharmacognosy, University of Beni-SuefBeni-Suef, Egypt.
- 245 10
- $a Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients / $c HM. Eid, ML. Wright, NV. Anil Kumar, A. Qawasmeh, STS. Hassan, A. Mocan, SM. Nabavi, L. Rastrelli, AG. Atanasov, PS. Haddad,
- 520 9_
- $a Metabolic syndrome is a cluster of three or more metabolic disorders including insulin resistance, obesity, and hyperlipidemia. Obesity has become the epidemic of the twenty-first century with more than 1.6 billion overweight adults. Due to the strong connection between obesity and type 2 diabetes, obesity has received wide attention with subsequent coining of the term "diabesity." Recent studies have identified unique contributions of the immensely diverse gut microbiota in the pathogenesis of obesity and diabetes. Several mechanisms have been proposed including altered glucose and fatty acid metabolism, hepatic fatty acid storage, and modulation of glucagon-like peptide (GLP)-1. Importantly, the relationship between unhealthy diet and a modified gut microbiota composition observed in diabetic or obese subjects has been recognized. Similarly, the role of diet rich in polyphenols and plant polysaccharides in modulating gut bacteria and its impact on diabetes and obesity have been the subject of investigation by several research groups. Gut microbiota are also responsible for the extensive metabolism of polyphenols thus modulating their biological activities. The aim of this review is to shed light on the composition of gut microbes, their health importance and how they can contribute to diseases as well as their modulation by polyphenols and polysaccharides to control obesity and diabetes. In addition, the role of microbiota in improving the oral bioavailability of polyphenols and hence in shaping their antidiabetic and antiobesity activities will be discussed.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Wright, Michelle L $u Nell Hodgson Woodruff School of Nursing, Emory UniversityAtlanta, GA, United States.
- 700 1_
- $a Anil Kumar, N V $u Department of Chemistry, Manipal Institute of Technology, Manipal UniversityManipal, India. $7 gn_A_00007054
- 700 1_
- $a Qawasmeh, Abdel $u Faculty of Pharmacy, Hebron UniversityHebron, Palestine.
- 700 1_
- $a Hassan, Sherif T S $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences BrnoBrno, Czechia.
- 700 1_
- $a Mocan, Andrei $u Department of Pharmaceutical Botany, Iuliu Hatieganu University of Medicine and PharmacyCluj-Napoca, Romania. ICHAT and Institute for Life Sciences, University of Agricultural Sciences and Veterinary MedicineCluj-Napoca, Romania.
- 700 1_
- $a Nabavi, Seyed M $u Applied Biotechnology Research Center, Baqiyatallah University of Medical SciencesTehran, Iran.
- 700 1_
- $a Rastrelli, Luca $u Dipartimento di Farmacia, University of SalernoFisciano, Italy.
- 700 1_
- $a Atanasov, Atanas G $u Institute of Genetics and Animal Breeding, Polish Academy of SciencesJastrzebiec, Poland. Department of Pharmacognosy, University of ViennaVienna, Austria. Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of ViennaVienna, Austria. $7 gn_A_00009691
- 700 1_
- $a Haddad, Pierre S $u Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology and Physiology, Université de MontréalMontréal, QC, Canada. Canadian Institutes of Health Research Team in Aboriginal Antidiabetic MedicinesMontréal, QC, Canada.
- 773 0_
- $w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 8, č. - (2017), s. 387
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28713266 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171030122932 $b ABA008
- 999 __
- $a ind $b bmc $g 1255647 $s 993081
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 8 $c - $d 387 $e 20170630 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
- LZP __
- $a Pubmed-20171025